Navigation Links
Takeda's investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole
Date:10/6/2008

Combined results from two Phase 3 studies presented at the American College of Gastroenterology Annual Scientific Meeting (ACG) in Orlando, Fla., demonstrated that TAK-390MR resulted in higher healing rates than lansoprazole among patients with more severe grades of erosive esophagitis (EE). TAK-390MR combines dexlansoprazole with a Dual Delayed Release (DDR) formulation, designed to provide two separate releases of drug for extended duration of acid suppression.

"These data are encouraging, as they suggest that TAK-390MR may provide an innovative new treatment option for patients with GERD, including those with more severe grades of erosive esophagitis," said David Peura, M.D., professor of medicine, University of Virginia Health System.

As part of the Phase 3 clinical trials, 4,092 patients were assessed for overall EE healing at week eight in two identically designed trials. Patients were randomized to receive 60 mg or 90 mg of TAK-390MR or 30 mg of lansoprazole. A retrospective, integrated analysis showed the difference in healing rates, or therapeutic gains, between 60 mg and 90 mg of TAK-390MR and 30 mg of lansoprazole, increased as the severity of EE increased. Therapeutic gains were greatest in patients with the most severe grade of EE (grade D): 12 percent for 60 mg (n=74) and 20 percent for 90 mg (n=83) of TAK-390MR. There were no significant differences in adverse events observed between the treatment groups.

"The development of TAK-390MR is another example of Takeda's commitment to patients who suffer from GERD and erosive esophagitis," said Dr. Stuart Atkinson, vice president of clinical science at Takeda. "TAK-390MR has the potential to serve as an important new treatment option for physicians and patients. If approved, it would be the first PPI that employs a dual delayed release formulation, delivering medication in two separate releases."

Additional TAK-390MR data being presented at ACG includes:


'/>"/>
Contact: Geoff Curtis
gcurtis@wcpglobal.com
312-550-8138
WeissComm Partners
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage
2. NEW DATA FOR PAZOPANIB - GSKS LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS
3. Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms
4. UAB study shows investigational drug may treat biliary cancers
5. Investigational anti-restenosis drug pimecrolimus disappoints
6. Investigational drug tested for preventing muscle fiber death in muscular dystrophy
7. Enrollment completed in 2 pivotal phase III studies of the investigational cancer drug vandetanib
8. New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets
9. UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
10. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
11. MetaCure(TM) Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 With the advent of ... enjoying the feel of warm breezes on bare skin. And ... on how to look their best in shorts, tank tops ... more people are turning to laser treatments for permanent hair ... Simply Posh Aesthetic Spa . “They're all veterans of ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 “We currently have larger ... states Marta Phillips, owner of SunGrubbies.com. “We felt it was ... to find a fashionable sun hat in an extra large size ... event.” , Fashionable derby sun hats such as the ... brim are now available in an extra large size , ...
(Date:5/5/2015)... San Francisco, Calif. (PRWEB) May 05, 2015 ... available online but these have focused primarily on personal ... the National Directory of Insurance (NDOI.com) has ... licensed insurance agents in the U.S. to present their ... public marketplace. , The result is significant and two-fold. ...
(Date:5/5/2015)... No one cares about health problems until they ... Prevention cite multiple sources causing poor indoor air quality ... quality (pollution) can bother your eyes, nose, and throat. It ... cancer.” , Toxic chemicals often get into the human body. ... or in some cases, absorb them through our skin. This ...
(Date:5/4/2015)... Visiopharm, the leader in image analysis for diagnostic ... round of financing with NorthCap Partners . The ... Visiopharm to further accelerate business growth and strengthen their ... diagnostic digital pathology solutions. , "It has been exciting ... solution has energized the pathologists, and how fast we ...
Breaking Medicine News(10 mins):Health News:Laser Hair Removal: Tips for Summertime Grooming 2Health News:Laser Hair Removal: Tips for Summertime Grooming 3Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Launches Their New Extra Large Size Fashion Sun Hats Collection 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 3Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 2Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 3
... with Patient Outcome in Neuroblastoma , Expression of ... patients whose tumors lacked CHD5 expression were more likely ... patients whose tumors expressed CHD5. , Neuroblastoma tumors often ... arm of chromosome 1, called 1p36.31. Garrett Brodeur, M.D., ...
... compromised blood, oxygen supply, study suggests , , TUESDAY, June ... name Namenda) may help reduce a form of brain ... Children,s Hospital Boston study. , Hypoxic-ischemia, a compromise ... to cerebral palsy and cognitive/behavioral problems. , In experiments ...
... VIEW, Calif., June 24 MAP,Pharmaceuticals, Inc. ... Telesso,Technologies Limited, formerly Eiffel Technologies Limited ("Eiffel"), ... Pharmaceuticals previously licensed,intellectual property and know-how, as ... to its supercritical fluid technology ("SCF")., ...
... Lack of Provisions for African American,Dialysis Patients, ... Tubbs Jones released this statement regarding the ... 2008. This legislation,prevents the pending 10 percent ... preventive and mental health benefits, improves,and extends ...
... Access To Community,Pharmacies, ALEXANDRIA, Va., June 24 ... 59 in favor of H.R. 6331, which represents ... critical,provisions for community pharmacies that speed up the ... to Medicaid generic,prescription drug reimbursement that would have ...
... LOS ANGELES, June 24 Sport Chalet, Inc.,(Nasdaq: ... opening of its new,50,500 sq. ft. store located at ... now has 52 Sport Chalet locations., A grand ... 27th,through Sunday, June 29th. Activities will include celebrity appearances,sports ...
Cached Medicine News:Health News:Also in the June 24 JNCI 2Health News:Also in the June 24 JNCI 3Health News:Also in the June 24 JNCI 4Health News:Also in the June 24 JNCI 5Health News:Alzheimer's Drug May Reduce Preemie Brain Injury 2Health News:MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited 2Health News:MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited 3Health News:Tubbs Jones Supports Medicare Improvements Bill 2Health News:Sport Chalet Opens Store in West Los Angeles 2
(Date:5/4/2015)... 4, 2015  Landauer, Inc. (NYSE: LDR ), ... and monitoring, outsourced medical physics services and high quality ... results for the fiscal second quarter 2015 after the ... The Company will also host a conference call ... p.m. Central Time (5:00 p.m. Eastern Time). Investors may ...
(Date:5/4/2015)... 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... development and commercialization of innovative therapies for the ... a regulatory update on Zalviso and reported financial ... 2015. Zalviso Regulatory UpdateOn April 21, ... of Anesthesia, Analgesia, and Addiction Products (DAAAP or ...
(Date:5/4/2015)... 4, 2015  Fox Three Partners, LLC ("Fox ... lower middle market, announced today the acquisition of ... and based in Newport News, Virginia ... radiation products for medical professionals as well as ... Capital Partners ("Peninsula"), an investment company specializing in ...
Breaking Medicine Technology:Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Second Quarter 2015 Results And Conference Call 2AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results 2AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results 3AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results 4AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results 5AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results 6AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results 7AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results 8Fox Three Partners, LLC Acquires Burlington Medical Supplies, Inc. 2
... 3, 2011 Hologic, Inc. (Hologic or the Company) ... and supplier of premium diagnostics products, medical imaging systems ... of women, today announced that it has appointed Christiana ... Ms. Stamoulis will serve on the Company,s Corporate Development ...
... advances have had a profound effect on how organizations ... evolving communication environment, companies need to continuously adjust their ... challenging, however, to gauge the effectiveness of all the ... internal and external communication options. In ...
Cached Medicine Technology:Hologic Announces Appointment of New Director 2Internal and External Communication Insights: Effective Approaches for Reaching Clients and Co-Workers 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid STR, a microbial identification system....
Medicine Products: